| HCC | Hepatocellular Carcinoma |
| HSC | Hepatic Stellate Cells |
| NASH | Nonalcoholic Steatohepatitis |
| IR | Insulin Resistance |
| FFA | Free Fatty Acids |
| MMPs | Metalloproteinases |
| ECM | Extracellular Matrix Protein |
| LSECs | Liver Sinusoidal Endothelial Cells |
| TIMPs | Tissue Inhibitors of MMPs |
| LFC | Liver Fat Content |
| FGF | Fibroblast growth factor |
| HFF | Hepatic Fat Fraction |
| THR | Thyroid Hormone Receptor |
| FXR | Farnesoid X Receptor |
| VLDL | Very Low-density Lipoprotein |
| HDL | High-density Lipoprotein |
| PPARs | Peroxisomal Proliferator-activated Receptors |
| GLP-1 | Glucagon-like Peptide-1 |
| GIP | Gastric Inhibitory Polypeptide |
| CCR2 | C-C chemokine receptor 2 |
| MPC | Mitochondrial Pyruvate Carrier |
| ALD | Alcoholic Liver Disease |
| HVPG | Hepatic Venous Pressure Gradient |
| HSP47 | Heat Shock Protein 47 |
| siRNA | Small Interfering RNA |
| ACE-1 | Angiotensin-I Converting Enzyme 1 |
| AT-II | Angiotensin-II |
| RAS | Renin-angiotensin System |
| ADCC | Antibody-dependent Cellular Cytotoxicity |
| PDGF | Platelet-derived Growth Factor |
| VEGF | Vascular Endothelial Growth Factor |
| FGF | Fibroblast Growth Factor |
| EGF | Epidermal Growth Factor |
| PVP | Portal Vein Pressure |
| MCD | Methionine and Choline-deficient Diet |
| ROS | Reactive Oxygen Species |
| HFD | High-Fat Diet |
| CYP2E1 | Cytochrome P450 2E1 |
| HA | Hyaluronic Acid |
| Bcl-2 | B-cell Lymphoma-2 |
| HFHS | High-Fat High-Sucrose |
| ALP | Alkaline Phosphatase |
| a-SMA | alpha-Smooth Muscle Actin |
| TGF-b1 | Transforming Growth Factor-b 1 |
| CDAA | Choline-deficient-amino-acid–defined |
| CPT-1 | Carnitine Palmitoyl Transferase-1 |
| ASGPR | Asialoglycoprotein Receptor |
| Chol | Cholesterol |
| IGF2R | Insulin-like Growth Factor 2 Receptor |
| CD44 | Cluster of Differentiation 44 |
| RBP | Retinol-binding Protein |
| TRAIL | TNF-related Apoptosis-inducing Ligand |
| NPs | Nanoparticles |
| cRGD | cyclic RGD |
| LNPs | Lipid Nanoparticles |